AMY AVANT: Open Payments
NPI 1568831584 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 117 payments from 19 companies in 2025. Trend: 2023 $2,012 · 2024 $3,708 · 2025 $2,416
Food & beverage: $2,319Education: $97
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 23 | $426 |
| ABBVIE INC. | 19 | $314 |
| UCB, Inc. | 10 | $288 |
| Janssen Biotech, Inc. | 9 | $224 |
| Galderma Laboratories, L.P. | 20 | $191 |
| Regeneron Healthcare Solutions, Inc. | 5 | $191 |
| Mallinckrodt Hospital Products Inc. | 2 | $153 |
| Amgen Inc. | 5 | $98 |
| Arcutis Biotherapeutics, Inc. | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
Products named: Sotyktu, Bimzelx, SKYRIZI, TREMFYA, DUPIXENT, ACTHAR, NEMLUVIO, OTEZLA.
Industry payments across KS — which companies pay providers there.
